Sorafenib in combination with paclitaxel for locally recurrent or metastatic breast cancer

Fulvestrant 250 mg vs 500 mg in postmenopausal women with oestrogen receptor-positive advanced breast cancer

Targeting intrinsically-resistant breast cancer stem cells with gamma-secretase inhibitors

Short term biological effects of the combination of letrozole and zoledronic acid on invasive breast cancer

Denosumab versus zoledronic acid for skeletal-related events in breast cancer patients with bone metastases

Use of bisphosphonates and risk of postmenopausal breast cancer

Oral bisphosphonate and breast cancer: prospective results from the Women's Health Initiative (WHI)

Translation of endocrine systemic treatment

Using biology of tumours to predict effective therapies

Adult acute lymphoblastic leukaemia

Optimal way to use herceptin with adjuvant therapy

Cancer and the bone micro-environment